Abstract
Mucormycosis carries a high mortality rate with few therapeutic options available. We describe a man with pulmonary/splenic mucormycosis complicating hypoplastic myelodysplastic syndrome on a background of chronic kidney disease, who achieved a complete response with salvage isavuconazole therapy following intolerance of consecutive courses of liposomal amphotericin and posaconazole therapy.
Original language | English |
---|---|
Pages (from-to) | 36-39 |
Number of pages | 4 |
Journal | Medical Mycology Case Reports |
Volume | 11 |
DOIs | |
Publication status | Published - 1 Mar 2016 |
Keywords
- Isavuconazole
- Mucormycosis